Cancer Treatment in Low- and Middle-Income Countries

2020 ◽  
pp. 90-96
Author(s):  
Elizabeth Molyneux ◽  
Trijn Israels ◽  
Scott C. Howard
Keyword(s):  
Cancer Treatment ◽  
Continuous Quality Improvement ◽  
Paediatric Oncology ◽  
Global Networks ◽  
Middle Income ◽  
Treatment Regimens ◽  
Middle Income Countries ◽  
Continuous Quality ◽  
Treatment Abandonment ◽  
Low And Middle Income

eCancer treatment in low- and middle-income countries (LMIC) differs substantially from that in high-income countries (HIC), and these differences are the focus of this chapter. In looking at these differences in cancer treatment, this chapter discusses healthcare disparities between LMIC and HIC, the importance of paediatric cancer units (PCU) (recruitment, training, and retention of personnel, continuous quality improvement, development of PCUs, and national paediatric oncology programmes), protocol-based care (adapted treatment regimens and clinical research, regional and global networks), treatment challenges in LMIC (toxicity of treatment, abandonment of treatment, palliative care), and advocacy.

scholarly journals Availability, Affordability, Access, and Pricing of Anti-cancer Medicines in Low- and Middle-Income Countries: A Systematic Review of Literature

2021 ◽  
Vol 9 ◽  
Author(s):  
Phyllis Ocran Mattila ◽  
Rabbiya Ahmad ◽  
Syed Shahzad Hasan ◽  
Zaheer-Ud-Din Babar
Keyword(s):  
Systematic Review ◽  
Low Income ◽  
Original Research ◽  
Multiple Stakeholders ◽  
Middle Income ◽  
Middle Income Countries ◽  
Anti Cancer ◽  
Huge Impact ◽  
Treatment Abandonment ◽  
Low And Middle Income

Background: Cancer is the second leading cause of death globally accounting for more than half of deaths in Low- and Middle-Income Countries (LMICs). Cancer treatment is expensive and the high prices of cancer medicines have a huge impact on access in LMICs. Scarcity of pricing or affordability data is one of the major barriers in the development of effective and transparent pricing policies in LMICs. This study aimed to conduct a systematic review of the literature regarding pricing, availability, affordability, and access to anti-cancer medicines in LMICs.Method: A systematic search was conducted across six electronic databases: PubMed, Medline/CINAHL (EBSCO), Web of Science, Springer Links, Scopus, and Google Scholar. The literature (from 2015 to 2020) was reviewed to identify original research articles published in English.Results: A total of 13 studies were included in the review with some having multiple outcomes: five studies on pricing, four studies addressed affordability, five studies reported on availability, and four studies on access to anti-cancer medicines. The studies showed that in LMICs, there are wide variations in cancer prices and availability amongst the medicine brands and across different countries, with less affordability by patients with low-income levels, sometimes leading to treatment abandonment.Conclusion: Given the importance of medicine availability and prices in patient access and medicine buying capacity of governments, multi-pronged policy and program approaches by multiple stakeholders are needed to ensure access to cancer medicines.

Some Conditions for Task Shifting in Low and Middle-Income Countries

2012 ◽  
Author(s):  
Joop de Jong ◽  
Mark Jordans ◽  
Ivan Komproe ◽  
Robert Macy ◽  
Aline & Herman Ndayisaba ◽  
...  
Keyword(s):  
Task Shifting ◽  
Middle Income ◽  
Middle Income Countries ◽  
Low And Middle Income
Sign in / Sign up

Export Citation Format

Share Document